GlassScriptPhysician profile
Jonathan R Mcdonagh
NPI 1972609949
$8,544.29
in general payments reported to CMS, 2019-2025
28 companies · $2,348 in 2025
The $2,348 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,231 · 2020: $772 · 2021: $739 · 2022: $941 · 2023: $983 · 2024: $530 · 2025: $2,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,803 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,802.77 |
| Travel and Lodging | $1,058.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,451.69 | 2019-2025 | Triclip, Mitraclip, Coroflow |
| Edwards Lifesciences Corporation | $1,240.43 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $886.87 | 2019-2024 | Avvigo Guidance System, Stingray, Rotapro |
| Medtronic, INC. | $812.65 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Medtronic Vascular, INC. | $480.78 | 2019-2020 | |
| Abiomed | $318.65 | 2019-2023 | Impella |
| Amgen INC. | $228.50 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $156.06 | 2019-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $125.14 | 2021 | |
| Teleflex LLC | $97.03 | 2024 | Turnpike |
| Novartis Pharmaceuticals Corporation | $96.94 | 2019-2025 | |
| Cleerly, INC. | $93.21 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Getinge USA Sales, LLC | $72.44 | 2021 | |
| Bard Peripheral Vascular, INC. | $70.73 | 2019 | |
| W. L. Gore & Associates, INC. | $46.05 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $42.98 | 2019-2022 | |
| Pfizer INC. | $41.73 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $38.47 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $38.37 | 2019-2021 | |
| Stryker Corporation | $32.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $29.47 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $27.38 | 2025 | Verquvo |
| Penumbra, INC. | $25.12 | 2021-2022 | |
| Philips North America LLC | $23.48 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.91 | 2024 | |
| Siemens Medical Solutions USA, INC. | $18.68 | 2021 | |
| Portola Pharmaceuticals, LLC | $14.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mcdonagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.